These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1036946)

  • 1. [Efficacy of diflucortolone valerate in the vasoconstriction tests].
    Wendt VH; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1495-8. PubMed ID: 1036946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1504-9. PubMed ID: 795434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
    Wendt H; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
    Reckers R; Wendt H
    Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicological examination of pure diflucortolone valerate and its formulations as ointment, fatty ointment and cream in animal experiments (author's transl)].
    Günzel VP; Etreby MF; Bhargava AS; Poggel HA; Schöbel C; Schuppler J; Siegmund F; Staben P
    Arzneimittelforschung; 1976; 26(7b):1476-9. PubMed ID: 1036942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous absorption of diflucortolone valerate in guinea pigs and man (author's transl)].
    Täuber VU
    Arzneimittelforschung; 1976; 26(7b):1479-84. PubMed ID: 1036943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
    Täuber VU; Amin M; Fuchs P; Speck U
    Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].
    Langen M; Hernandez MS
    Z Hautkr; 1976; 51 Suppl 1():1-16. PubMed ID: 795179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the Pharmacology of 6alpha,9-difluoro-11beta-hydroxy-16alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione (diflucortolon valerate) (author's transl)].
    Kapp VJ; Koch H; Casals-Stenzel J; Töpert M; Gerhards E
    Arzneimittelforschung; 1976; 26(7b):1463-75. PubMed ID: 188428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study on the efficacy of diflucortolone valerate in the psoriasis plaque test (author's transl)].
    Lofferer O; Reckers R
    Arzneimittelforschung; 1978; 28(4):703-5. PubMed ID: 373772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biotransformation of diflucortolone valerate in the skin of rat, guinea pig and man (author's transl)].
    Täuber VU; Toda T
    Arzneimittelforschung; 1976; 26(7b):1484-7. PubMed ID: 1036940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diflucortolone valerianate (Nerisona) in the treatment of corticoid-sensitive dermatoses in childhood].
    Langen ML; Psenicka FG
    Z Hautkr; 1977 Dec; 52(24):1244-52. PubMed ID: 341552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
    Coleman GL; Kanfer I; Haigh JM
    Dermatologica; 1978; 156(4):224-30. PubMed ID: 342295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
    Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biologic availability of diflucortolone-21-valerate in human skin].
    Täuber U
    Arzneimittelforschung; 1983; 33(10):1503-7. PubMed ID: 6686053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative multicentre trial of halometasone/triclosan cream and diflucortolone valerate/chlorquinaldol cream in the treatment of acute dermatomycoses.
    Maeder E; Schindléry C; Macarol V; Schoenenberger PM
    J Int Med Res; 1983; 11 Suppl 1():48-52. PubMed ID: 6339293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical tests of the therapeutic effect of a new difluocortolone valerate cream].
    Gatti JC; Cardama E; Pizzariello GE; Luppi MS
    Z Hautkr; 1976; 51 Suppl 1():33-6. PubMed ID: 795185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
    Carvajal Rosado VM
    Z Hautkr; 1976; 51 Suppl 1():27-9. PubMed ID: 795183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.